Clinical trial NCT03097640: Understanding Perspectives of Frequently-Admitted Hospital Patients
Official title: Understanding Perspectives of Frequently-Admitted Hospital Patients
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Continuity of Patient Care
High Utilizers of Hospital Care
Patient-Centered Care
Lead sponsor: Northwestern University
Sponsor class: OTHER
First posted: 2017-03-31
Enrollment: 151
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: This study evaluates the clinical outcomes of a novel program designed to target patients who are high-utilizers of hospital services. Patients who are frequently admitted to medical services - "high-utilizers" - present a unique set of challenges to providers and the health care system that require a different way of approaching chronic illness. The Complex High Admission Management Program (CHAMP) is an innovative model of care consisting of a small team of providers who establish continuity relationships with high-utilizer patients. CHAMP strives to provide effective, high value care via a longitudinal relationship-based care model through provider continuity, intensive case management, and personalized care plans. To better understand the potential outcomes of CHAMP, this study is a longitudinal, prospective, randomized, controlled trial of medical high-utilizers enrolled in CHAMP compared to a group of high-utilizer patients receiving usual care.

Detailed description: Frequent users of hospital services, otherwise known as hospital "high-utilizers," comprise a diverse patient population that pose unique challenges to the current US health care delivery model. The Complex High Admission Management Program (CHAMP), implemented at Northwestern Memorial Hospital in Chicago, IL, seeks to improve care for high-utilizer patients through provider continuity, intensive case management, and developing personalized care plans that span inpatient, outpatient, and emergency care environments.

Preliminary evaluation of CHAMP has shown a 38% decrease in 30-day unplanned hospital readmissions and an 18% decrease in ED encounters over a 6-month time period, when compared to an equal time period pre-CHAMP.

Patients are eligible for the program if they are readmitted to the hospital three times within a twelve-month period. Due to the time and resource limitations of the CHAMP team, not all patients meeting these criteria can be enrolled at once. Patients will thus be randomly selected to be enrolled in CHAMP or will receive usual care. This study plans to evaluate the difference in outcomes between patients enrolled in CHAMP and those receiving usual care by answering the following questions:

To what extent do high-utilizer patients enrolled in CHAMP differ in their level of trust in providers, self-assessed coping skills, daily symptom burden, perceived functionality, and attitudes about the healthcare system when compared to a control group of high utilizer patients receiving usual care? We will assess patient responses to a series of surveys assessing trust, feelings of discrimination, activation, satisfaction with care, and level of social functioning.

What are the healthcare utilization rates of high-utilizer patients enrolled in CHAMP compared to a control group of high-utilizer patients receiving usual care? We will compare rates of (a) hospital admission and (b) utilization (including length of stay) among high-utilizer patients enrolled in CHAMP as compared to high-utilizer patients not enrolled in the program.

Eligibility criteria: Inclusion criteria:

* Adults (18 yrs of age or older) who are admitted to Northwestern Memorial Hospital (NMH) and identified by EDW search as having two unplanned 30-day inpatient readmissions to NMH within the prior 12 months with one of two additional criteria:at least 1 readmission in the last 6 months, or a referral from one of that patient's medical providers.
* Admission to NMH during the study period (October 1, 2016 to September 30, 2018) and meeting criteria described above for CHAMP
* Ability to consent for this study (including ability to read materials printed in English, understanding and communicating in English, and able to understand the risks and benefits of participating in the study).

Exclusion Criteria:

* Patients who are admitted to the Intensive Care Unit, patients admitted to Oncology services (as we have found that this latter group has a multidisciplinary care team already in place), or patients actively followed by the Heart Failure Bridge and Transition (BAT) Team, a different quality improvement intervention designed to reduce readmissions among patients admitted for acute decompensated heart failure.
* Participants will be excluded if they are disoriented to person, place, or time, or are unable to consent for any other reason.
* Minors, pregnant women, and prisoners will also be excluded.

Primary outcomes:
measure: Readmission Rate
timeFrame: 180-days from indexed hospital discharge
Secondary outcomes:
measure: Readmission Rate
timeFrame: 30 days from indexed hospital discharge
measure: Readmission Rate
timeFrame: 90 days from indexed hospital discharge
measure: Inpatient Admissions
timeFrame: 30 days from indexed hospital discharge
measure: Inpatient Admissions
timeFrame: 90 days from indexed hospital discharge
measure: Inpatient Admissions
timeFrame: 180 days from indexed hospital discharge
measure: Inpatient Admissions-total
timeFrame: 30 days from indexed hospital discharge
measure: Inpatient Admissions-total
timeFrame: 90 days from indexed hospital discharge
measure: Inpatient Admissions-total
timeFrame: 180 days from indexed hospital discharge
measure: ER Admissions
timeFrame: 180 days from indexed hospital discharge
measure: ER Admissions
timeFrame: 30 days from indexed hospital discharge
measure: ER Admissions
timeFrame: 90 days from indexed hospital discharge
measure: ER Admissions-total
timeFrame: 30 days from indexed hospital discharge
measure: ER Admissions-total
timeFrame: 90 days from indexed hospital discharge
measure: ER Admissions-total
timeFrame: 180 days from indexed hospital discharge
measure: Hospital Length of Stay
timeFrame: 180 days from indexed hospital discharge
measure: Hospital Length of Stay
timeFrame: 30 days from indexed hospital discharge
measure: Hospital Length of Stay
timeFrame: 90 days from indexed hospital discharge
measure: Clinic Visits
timeFrame: 180 days from indexed hospital discharge
measure: Patient-Centered Outcomes
timeFrame: 30 days from indexed hospital discharge
measure: Patient-Centered Outcomes
timeFrame: 90 days from indexed hospital discharge
measure: Patient-Centered Outcomes
timeFrame: 180 days from indexed hospital discharge
measure: Average costs
timeFrame: 180 days from indexed hospital discharge
Other outcomes:
Locations:
city: Chicago
country: United States
facility: Northwestern Memorial Hospital
state: Illinois
Study officials:
affiliation: Northwestern University Feinberg School of Medicine
name: Bruce L Henschen, MD/MPH
role: PRINCIPAL_INVESTIGATOR
References:
citation: Henschen BL, Theodorou ME, Chapman M, Barra M, Toms A, Cameron KA, Zhou S, Yeh C, Lee J, O'Leary KJ. An Intensive Intervention to Reduce Readmissions for Frequently Hospitalized Patients: the CHAMP Randomized Controlled Trial. J Gen Intern Med. 2022 Jun;37(8):1877-1884. doi: 10.1007/s11606-021-07048-1. Epub 2021 Sep 1.